Kestra Medical (KMTS) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$106.7M

Revenue (quarter)

$31.0M

Revenue growth (year over year)

+59.88%

Gross profit (trailing twelve months)

$57.5M

Gross margin

53.89%

Net income (trailing twelve months)

−$149.9M

Net income (quarter)

−$44.1M

Net income growth (year over year)

−70.71%

Net margin

−140.43%

Return on equity

−73.74%

EPS (trailing twelve months)

—

Book value per share

$3.79

P/E (trailing twelve months)

—

Price to book

7.22

Debt to assets

35.99%

Payout ratio

—

Dividend yield

—

Company profile

Kestra Medical Technologies Ltd is a commercial-stage wearable medical device and digital healthcare company focused on connected monitoring, therapeutic intervention, and data-driven clinical insights for cardiovascular disease. It has developed and is commercializing the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. The platform is anchored by the ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected. The platform also includes digital patient engagement and clinical workflow solutions.

• Is Kestra Medical (KMTS) profitable?

  No. Kestra Medical reported a net loss of $149.9M over the trailing twelve months.

• How much revenue does Kestra Medical (KMTS) make?

  Kestra Medical generated $106.7M in revenue over the trailing twelve months, up 59.88% year over year.

• How do I buy stock in Kestra Medical (KMTS)?

  KMTS trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.